Objective: Debilitating pain, occurring in 50–70% of multiple sclerosis (MS) patients, is
poorly understood and infrequently studied. We summarized efficacy and safety data of …

Medicinal cannabis has already entered mainstream medicine in some countries. This
systematic review (SR) aimed at evaluating the efficacy, acceptability and safety of cannabis …

Aims: To carry out a systematic review to assess the effectiveness of cannabis extracts and
cannabinoids in the management of chronic nonmalignant neuropathic pain. Methods …

BACKGROUND: The management of chronic pain is a complex challenge worldwide.
Cannabis-based medicines (CBMs) have proven to be efficient in reducing chronic pain …

Cannabinoids, cannabis, and cannabis-based medicines (CBMs) are increasingly used to
manage pain, with limited understanding of their efficacy and safety. We summarised …

Cannabinoids, cannabis, and cannabis-based medicines (CBM) are increasingly used to
manage pain, with limited understanding of their efficacy and safety. We assessed …

Background Chronic neuropathic pain (NP) presents therapeutic challenges. Interest in the
use of cannabis-based medications has outpaced the knowledge of its efficacy and safety in …

Abstract Purpose of Review Cannabis and cannabinoids have been used medically and
recreationally for thousands of years and recently there has been a growing body of …

Background Cannabinoids are often prescribed for neuropathic pain, but the evidence‐
based recommendation is 'weak against'. Objectives The aim was to examine the effect of …

Setting. Cannabis preparations have been used as a remedy for thousands of years in
traditional medicine. Clinical use of cannabinoid substances is restricted, due to legal and …